Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 1 of 1 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/25/23
End: 07/31/24
Due: 07/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A First in Human Study of AX-202 in Healthy Subjects and Patients With Psoriasis. | NCT05965089 | Arxx Therapeutics | user2@example.com | None | 2023-04-25 | 2024-07-31 | 2025-07-31 | - | - | 2025-07-14 |